A systematic review of drug therapy for Graves' hyperthyroidism.

  title={A systematic review of drug therapy for Graves' hyperthyroidism.},
  author={Prakash Abraham and A Avenell and Christine M Park and Wendy J Watson and John S. Bevan},
  journal={European journal of endocrinology},
  volume={153 4},
We assessed the effects of dose, regimen and duration of anti-thyroid drug therapy for Graves' thyrotoxicosis on recurrence of hyperthyroidism, course of ophthalmopathy, adverse effects, health-related quality of life and economic outcomes. We undertook a systematic review and meta-analyses of randomised controlled trials (RCTs). We identified RCTs regardless of language or publication status by searching six databases, and trial registries. Dual, blinded data abstraction and quality assessment… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 48 extracted citations

2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

Thyroid : official journal of the American Thyroid Association • 2016
View 4 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 32 references

Effect of long-term continuous methimazole treatment of thyrotoxicosis: comparison with radioiodine

F Azizi, L Ataie, M Hedayati, Y Mehrabi, F. Shiekholeslami
European Journal of Endocrinology • 2005

Medikamentose behandliung der immunehyperthreose (typ morbus Basedow) patientselektion, langzeitverlauf und rezidivprophylaxe

B Quadbeck, R Hoermann, OE Janssen, K. Mann
Internist • 2003
View 1 Excerpt

Effects of antithyroid drugs alone and plus L-thyroxine on the relapse of Graves’ disease

E Tuncel, E Ertturk, S. Imamoglu
Journal of Endocrinological Investigation • 2000

Epidemologie clinique de la maladie de Basedow en Belgique

D Glinoer
Revue Medicale de Bruxelles • 2000

Similar Papers

Loading similar papers…